A reduced glomerular filtration rate (GFR) will affect the pharmacokinetics of low molecular weight heparin (LMWH), and the low density of antithrombin-III in patients with liver cirrhosis may lead to heparin resistance [21]. This evidence concerns the gene SERPINC1 and cirrhosis of liver.